دوره 1، شماره 1 - ( 10-1388 )                   جلد 1 شماره 1 صفحات 8-5 | برگشت به فهرست نسخه ها

XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Heidari B, Ghazi Mirsaeid M A, Khossosi Niaki M R, Heidari P. Prevalence of hypercholesterolemia in hypothyroidism compared with euthyroid controls: effects of levothyroxin replacement therapy. Caspian J Intern Med 2010; 1 (1) :5-8
URL: http://caspjim.com/article-1-61-fa.html
Prevalence of hypercholesterolemia in hypothyroidism compared with euthyroid controls: effects of levothyroxin replacement therapy. . 1388; 1 (1) :5-8

URL: http://caspjim.com/article-1-61-fa.html


چکیده:   (9631 مشاهده)
Background: Hypothyroidism (HT), a relatively common condition among general population is associated with lipid profile abnormalities. The present study was designed to determine the contributive role of HT in the development of hypercholesterolemia (HCH).
Methods: One hundred thirty six consecutive patients with HT and 272 euthyroid controls entered the study. Serum total cholesterol (CH) level was determined before and after treatment of HT and compared with controls. Frequency of subjects with HCH defined as plasma total CH level >240 mg/dl, were determined and compared between hypothyroid patients and sex - age-matched controls. The contributive role of HT in the development of HCH was determined by the comparison of pre-treatment and post-treatment CH levels. HT-induced HCH was regarded as restoration of HCh (reduction of CH level to less than 240 (mg/d) after achievement of euthyroid state with thyroid hormone.
Results: The mean ages of patients and controls were 43±13 and 44±13 years, respectively. In HT patients the frequency of HCH and mean level of Ch were significantly higher compared with sex and age-matched euthyroid controls. Replacement therapy of 44 HT patients resulted to a significant reduction of CH level from baseline by 22% (p<0.0001) in the whole number of patients, and reduction of 32.2% (p<0.0001) along with the restoration of HCH in 22(50%) patients. Whereas, in 22 patients after achievement of euthyroid state, despite a significant reduction of Ch from baseline (12%, p<0.05), HCH persisted and CH levels remained>240mg/dl.
Conclusion: The results show contributive role for HT in the development of HCH. Two different populations of HCH with different responses to replacement therapy is recognizable in HT.
متن کامل [PDF 73 kb]   (1967 دریافت)    
نوع مطالعه: Original Article | موضوع مقاله: Infectious Diseases
دریافت: 1392/10/24 | پذیرش: 1392/10/24 | انتشار: 1392/10/24

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2025 CC BY-NC 4.0 | Caspian Journal of Internal Medicine

Designed & Developed by : Yektaweb